• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种与透明细胞肾细胞癌的预后和免疫浸润格局相关的新型失巢凋亡相关预后特征。

A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma.

作者信息

Chen Zhuo, Liu Xiao, Zhu Zhengjie, Chen Jinchao, Wang Chen, Chen Xi, Zhu Shaoxing, Zhang Aiqin

机构信息

The Cancer Hospital of the University of Chinese Academy of Sciences (Zhejiang Cancer Hospital), Institute of Basic Medicine and Cancer (IBMC), Chinese Academy of Sciences, Hangzhou, China.

Shaoxing TCM Hospital Affiliated to Zhejiang Chinese Medical University, Shaoxing, Zhejiang, China.

出版信息

Front Genet. 2022 Oct 19;13:1039465. doi: 10.3389/fgene.2022.1039465. eCollection 2022.

DOI:10.3389/fgene.2022.1039465
PMID:36338978
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9627172/
Abstract

Clear cell renal cell carcinoma (ccRCC) is the most common histological subtype of renal cell carcinoma (RCC). Anoikis plays an essential function in tumourigenesis, whereas the role of anoikis in ccRCC remains unclear. Anoikis-related genes (ARGs) were collected from the MSigDB database. According to univariate Cox regression analysis, the least absolute shrinkage and selection operator (LASSO) algorithm was utilized to select the ARGs associated with the overall rate (OS). Multivariate Cox regression analysis was conducted to identify 5 prognostic ARGs, and a risk model was established. The Kaplan-Meier survival analysis was used to evaluate the OS rate of ccRCC patients. Gene ontology (GO), Kyoto encyclopedia of genes and genomes (KEGG), and Gene set enrichment analysis (GSVA) were utilized to investigate the molecular mechanism of patients in the low- and high-risk group. ESTIMATE, CIBERSOT, and single sample gene set enrichment analysis (ssGSEA) algorithms were conducted to estimate the immune infiltration landscape. Consensus clustering analysis was performed to divide the patients into different subgroups. A fresh risk model was constructed based on the 5 prognostic ARGs (). The Kaplan-Meier survival analysis indicated that the OS rate of patients with a low-risk score was significantly higher than those with a high-risk score. Consensus clustering analysis successfully clustered the patients into two subgroups, with a remarkable difference in immune infiltration landscape and prognosis. The ESTIMATE, CIBERSORT, and ssGSEA results illustrated a significant gap in immune infiltration landscape of patients in the low- and high-risk group. Enrichment analysis and GSVA revealed that immune-related signaling pathways might mediate the role of ARGs in ccRCC. The nomogram results illustrated that the ARGs prognostic signature was an independent prognostic predictor that distinguished it from other clinical characteristics. TIDE score showed a promising immunotherapy response of ccRCC patients in different risk subgroups and cluster subgroups. Our study revealed that ARGs play a carcinogenic role in ccRCC. Additionally, we firstly integrated multiple ARGs to establish a risk-predictive model. This study highlights that ARGs could be implemented as a stratification factor for individualized and precise treatment in ccRCC patients.

摘要

透明细胞肾细胞癌(ccRCC)是肾细胞癌(RCC)最常见的组织学亚型。失巢凋亡在肿瘤发生中起重要作用,而失巢凋亡在ccRCC中的作用仍不清楚。从MSigDB数据库收集失巢凋亡相关基因(ARGs)。根据单因素Cox回归分析,利用最小绝对收缩和选择算子(LASSO)算法选择与总生存率(OS)相关的ARGs。进行多因素Cox回归分析以鉴定5个预后ARGs,并建立风险模型。采用Kaplan-Meier生存分析评估ccRCC患者的OS率。利用基因本体(GO)、京都基因与基因组百科全书(KEGG)和基因集富集分析(GSVA)研究低风险和高风险组患者的分子机制。采用ESTIMATE、CIBERSOT和单样本基因集富集分析(ssGSEA)算法评估免疫浸润情况。进行一致性聚类分析以将患者分为不同亚组。基于5个预后ARGs构建了一个新的风险模型。Kaplan-Meier生存分析表明,低风险评分患者的OS率显著高于高风险评分患者。一致性聚类分析成功地将患者分为两个亚组,免疫浸润情况和预后存在显著差异。ESTIMATE、CIBERSORT和ssGSEA结果表明,低风险和高风险组患者的免疫浸润情况存在显著差异。富集分析和GSVA显示,免疫相关信号通路可能介导ARGs在ccRCC中的作用。列线图结果表明,ARGs预后特征是一个独立的预后预测指标,与其他临床特征不同。TIDE评分显示,不同风险亚组和聚类亚组的ccRCC患者具有良好的免疫治疗反应。我们的研究表明,ARGs在ccRCC中起致癌作用。此外,我们首次整合多个ARGs建立了一个风险预测模型。本研究强调,ARGs可作为ccRCC患者个体化精准治疗的分层因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/20b0eb88685b/fgene-13-1039465-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/f3213909fca9/fgene-13-1039465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/7ee3766ad415/fgene-13-1039465-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/5476baf5d8a6/fgene-13-1039465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/5fdc1e0afeb8/fgene-13-1039465-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/1779d13f4dab/fgene-13-1039465-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/87b2646bffa6/fgene-13-1039465-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/a3adadce604f/fgene-13-1039465-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/946333507b45/fgene-13-1039465-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/20b0eb88685b/fgene-13-1039465-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/f3213909fca9/fgene-13-1039465-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/7ee3766ad415/fgene-13-1039465-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/5476baf5d8a6/fgene-13-1039465-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/5fdc1e0afeb8/fgene-13-1039465-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/1779d13f4dab/fgene-13-1039465-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/87b2646bffa6/fgene-13-1039465-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/a3adadce604f/fgene-13-1039465-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/946333507b45/fgene-13-1039465-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/61e4/9627172/20b0eb88685b/fgene-13-1039465-g009.jpg

相似文献

1
A novel anoikis-related prognostic signature associated with prognosis and immune infiltration landscape in clear cell renal cell carcinoma.一种与透明细胞肾细胞癌的预后和免疫浸润格局相关的新型失巢凋亡相关预后特征。
Front Genet. 2022 Oct 19;13:1039465. doi: 10.3389/fgene.2022.1039465. eCollection 2022.
2
Development of a prognostic model to predict BLCA based on anoikis-related gene signature: preliminary findings.基于无附著凋亡相关基因特征的 BLCA 预后模型的建立:初步研究结果。
BMC Urol. 2023 Dec 4;23(1):199. doi: 10.1186/s12894-023-01382-8.
3
Identification and verification of a novel anoikis-related gene signature with prognostic significance in clear cell renal cell carcinoma.鉴定和验证与透明细胞肾细胞癌预后相关的新型凋亡相关基因特征。
J Cancer Res Clin Oncol. 2023 Oct;149(13):11661-11678. doi: 10.1007/s00432-023-05012-6. Epub 2023 Jul 5.
4
Anoikis-related subtype and prognosis analyses based on bioinformatics, and an expression verification of ANGPTL4 based on experiments of lung adenocarcinoma.基于生物信息学的失巢凋亡相关亚型及预后分析,以及基于肺腺癌实验的ANGPTL4表达验证。
J Thorac Dis. 2024 Aug 31;16(8):5361-5378. doi: 10.21037/jtd-24-1123. Epub 2024 Aug 28.
5
Development and validation of a novel anoikis-related gene signature in clear cell renal cell carcinoma.一种新型的与失巢凋亡相关的基因特征在透明细胞肾细胞癌中的开发与验证
Front Oncol. 2023 Oct 26;13:1211103. doi: 10.3389/fonc.2023.1211103. eCollection 2023.
6
An anoikis-based gene signature for predicting prognosis in malignant pleural mesothelioma and revealing immune infiltration.一种基于细胞凋亡的基因签名,用于预测恶性胸膜间皮瘤的预后并揭示免疫浸润。
J Cancer Res Clin Oncol. 2023 Oct;149(13):12089-12102. doi: 10.1007/s00432-023-05128-9. Epub 2023 Jul 8.
7
Establishment and validation of a novel anoikis-related prognostic signature of clear cell renal cell carcinoma.建立并验证一种新型的与细胞黏附丧失相关的肾透明细胞癌预后标志物。
Front Immunol. 2023 Mar 28;14:1171883. doi: 10.3389/fimmu.2023.1171883. eCollection 2023.
8
Validation and identification of anoikis-related lncRNA signatures for improving prognosis in clear cell renal cell carcinoma.验证和鉴定与细胞凋亡相关的 lncRNA 标志物,以改善透明细胞肾细胞癌的预后。
Aging (Albany NY). 2024 Feb 21;16(4):3915-3933. doi: 10.18632/aging.205568.
9
Development of a prognostic model based on anoikis-related genes for predicting clinical prognosis and immunotherapy of hepatocellular carcinoma.基于失巢凋亡相关基因的预测肝细胞癌临床预后和免疫治疗的预后模型的建立。
Aging (Albany NY). 2023 Oct 2;15(19):10253-10271. doi: 10.18632/aging.205073.
10
Construction and Validation of an Autophagy-Related Prognostic Risk Signature for Survival Predicting in Clear Cell Renal Cell Carcinoma Patients.用于预测透明细胞肾细胞癌患者生存的自噬相关预后风险特征的构建与验证
Front Oncol. 2020 May 5;10:707. doi: 10.3389/fonc.2020.00707. eCollection 2020.

引用本文的文献

1
Anoikis-related genes predicts prognosis and therapeutic response in renal cell carcinoma.失巢凋亡相关基因可预测肾细胞癌的预后和治疗反应。
Ann Med. 2025 Dec;57(1):2548042. doi: 10.1080/07853890.2025.2548042. Epub 2025 Aug 19.
2
A novel anoikis related gene prognostic model for colorectal cancer based on single cell sequencing and bulk transcriptome analyses.一种基于单细胞测序和批量转录组分析的新型结直肠癌失巢凋亡相关基因预后模型。
Sci Rep. 2025 Aug 18;15(1):30155. doi: 10.1038/s41598-025-15389-8.
3
CENPF as a Potential Biomarker Associated with the Immune Microenvironment of Renal Cancer.

本文引用的文献

1
Adjuvant immunotherapy for renal cell carcinoma.肾细胞癌的辅助免疫治疗
Lancet Oncol. 2022 Sep;23(9):1110-1111. doi: 10.1016/S1470-2045(22)00509-5.
2
Anoikis in cancer: The role of lipid signaling.细胞凋亡抵抗在癌症中的作用:脂信号的角色。
Cell Biol Int. 2022 Nov;46(11):1717-1728. doi: 10.1002/cbin.11896. Epub 2022 Aug 28.
3
Transformable ECM Deprivation System Effectively Suppresses Renal Cell Carcinoma by Reversing Anoikis Resistance and Increasing Chemotherapy Sensitivity.可变形细胞外基质剥夺系统通过逆转失巢凋亡抗性和增加化疗敏感性有效抑制肾细胞癌。
CENPF作为一种与肾癌免疫微环境相关的潜在生物标志物。
Technol Cancer Res Treat. 2025 Jan-Dec;24:15330338251330791. doi: 10.1177/15330338251330791. Epub 2025 Mar 31.
4
Prognostic analysis of anoikis-related genes in bladder cancer: An observational study.膀胱癌中与失巢凋亡相关基因的预后分析:一项观察性研究。
Medicine (Baltimore). 2024 Jul 19;103(29):e38999. doi: 10.1097/MD.0000000000038999.
5
Deciphering anoikis resistance and identifying prognostic biomarkers in clear cell renal cell carcinoma epithelial cells.解析透明细胞肾细胞癌上皮细胞中的失巢凋亡抵抗并鉴定预后生物标志物。
Sci Rep. 2024 May 27;14(1):12044. doi: 10.1038/s41598-024-62978-0.
6
Development of an anoikis-related gene signature and prognostic model for predicting the tumor microenvironment and response to immunotherapy in colorectal cancer.开发一种与细胞失巢凋亡相关的基因特征和预后模型,用于预测结直肠癌的肿瘤微环境和对免疫治疗的反应。
Front Immunol. 2024 May 8;15:1378305. doi: 10.3389/fimmu.2024.1378305. eCollection 2024.
7
Multi-cohort validation of Ascore: an anoikis-based prognostic signature for predicting disease progression and immunotherapy response in bladder cancer.多队列验证 Ascore:一种基于失巢凋亡的预测膀胱癌疾病进展和免疫治疗反应的预后标志物。
Mol Cancer. 2024 Feb 10;23(1):30. doi: 10.1186/s12943-024-01945-9.
8
Bioinformatics analysis identifies coagulation factor II receptor as a potential biomarker in stomach adenocarcinoma.生物信息学分析鉴定凝血因子 II 受体为胃腺癌的潜在生物标志物。
Sci Rep. 2024 Jan 30;14(1):2468. doi: 10.1038/s41598-024-52397-6.
9
Deciphering the significance of anoikis in bladder cancer and systematic analysis of S100A7 as a potential therapeutic target.解析膀胱癌中 anoikis 的意义及 S100A7 作为潜在治疗靶点的系统分析。
Eur J Med Res. 2024 Jan 12;29(1):52. doi: 10.1186/s40001-024-01642-9.
10
An anoikis-related lncRNA signature is a useful tool for predicting the prognosis of patients with lung adenocarcinoma.一种与失巢凋亡相关的长链非编码RNA特征是预测肺腺癌患者预后的有用工具。
Heliyon. 2023 Nov 11;9(11):e22200. doi: 10.1016/j.heliyon.2023.e22200. eCollection 2023 Nov.
Adv Mater. 2022 Oct;34(43):e2203518. doi: 10.1002/adma.202203518. Epub 2022 Sep 20.
4
SNAI2 promotes the malignant transformation of oral leukoplakia by modulating p-EMT.SNAI2 通过调节 p-EMT 促进口腔白斑的恶性转化。
Oral Dis. 2023 Nov;29(8):3232-3242. doi: 10.1111/odi.14321. Epub 2022 Aug 21.
5
Activity of ROCKII not ROCKI promotes pulmonary metastasis of melanoma cells via modulating Smad2/3-MMP9 and FAK-Src-VEGF signalling.ROCKII 的活性而非 ROCKI 通过调节 Smad2/3-MMP9 和 FAK-Src-VEGF 信号促进黑素瘤细胞的肺转移。
Cell Signal. 2022 Sep;97:110389. doi: 10.1016/j.cellsig.2022.110389. Epub 2022 Jun 17.
6
CHEK2 variants: linking functional impact to cancer risk.CHEK2 变异:将功能影响与癌症风险联系起来。
Trends Cancer. 2022 Sep;8(9):759-770. doi: 10.1016/j.trecan.2022.04.009. Epub 2022 May 25.
7
HMGN3 represses transcription of epithelial regulators to promote migration of cholangiocarcinoma in a SNAI2-dependent manner.HMGN3 通过抑制上皮调节因子的转录促进胆管癌细胞迁移,该过程依赖于 SNAI2。
FASEB J. 2022 Jul;36(7):e22345. doi: 10.1096/fj.202200386R.
8
SNAI2 promotes the development of ovarian cancer through regulating ferroptosis.SNAI2 通过调控铁死亡促进卵巢癌的发展。
Bioengineered. 2022 Mar;13(3):6451-6463. doi: 10.1080/21655979.2021.2024319.
9
A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro.一种 PDK-1 别构激动剂可中和神经元细胞中胰岛素信号转导紊乱和β淀粉样肽毒性,并在体外发挥作用。
PLoS One. 2022 Jan 21;17(1):e0261696. doi: 10.1371/journal.pone.0261696. eCollection 2022.
10
Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity.SNAI2 在前列腺癌中的动态表达预测肿瘤进展和药物敏感性。
Mol Oncol. 2022 Jul;16(13):2451-2469. doi: 10.1002/1878-0261.13140. Epub 2022 Feb 11.